146 related articles for article (PubMed ID: 14757112)
1. The testing of chemicals in the Syrian hamster embryo (SHE) cell transformation assay for assessment of carcinogenic potential.
Engelhardt G; Schwind KR; Mussler B
Toxicol In Vitro; 2004 Apr; 18(2):213-8. PubMed ID: 14757112
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the standard and reduced pH Syrian hamster embryo (SHE) cell in vitro transformation assays in predicting the carcinogenic potential of chemicals.
Isfort RJ; Kerckaert GA; LeBoeuf RA
Mutat Res; 1996 Sep; 356(1):11-63. PubMed ID: 8841474
[TBL] [Abstract][Full Text] [Related]
3. The syrian hamster embryo (SHE) cell transformation assay: review of the methods and results.
Mauthe RJ; Gibson DP; Bunch RT; Custer L
Toxicol Pathol; 2001; 29 Suppl():138-46. PubMed ID: 11695550
[TBL] [Abstract][Full Text] [Related]
4. The pH 6.7 Syrian hamster embryo cell transformation assay for assessing the carcinogenic potential of chemicals.
LeBoeuf RA; Kerckaert GA; Aardema MJ; Gibson DP; Brauninger R; Isfort RJ
Mutat Res; 1996 Sep; 356(1):85-127. PubMed ID: 8841476
[TBL] [Abstract][Full Text] [Related]
5. Use of the Syrian hamster embryo cell transformation assay for carcinogenicity prediction of chemicals currently being tested by the National Toxicology Program in rodent bioassays.
Kerckaert GA; Brauninger R; LeBoeuf RA; Isfort RJ
Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1075-84. PubMed ID: 8933057
[TBL] [Abstract][Full Text] [Related]
6. Use of the Syrian hamster embryo cell transformation assay for determining the carcinogenic potential of heavy metal compounds.
Kerckaert GA; LeBoeuf RA; Isfort RJ
Fundam Appl Toxicol; 1996 Nov; 34(1):67-72. PubMed ID: 8937893
[TBL] [Abstract][Full Text] [Related]
7. The Syrian hamster embryo (SHE) low pH cell transformation assay.
Pant K; Aardema MJ
Curr Protoc Toxicol; 2008 Feb; Chapter 20():Unit20.3. PubMed ID: 23045007
[TBL] [Abstract][Full Text] [Related]
8. Cell transformation assays.
Costa M; Sutherland JE
Curr Protoc Toxicol; 2001 May; Chapter 3():Unit3.4. PubMed ID: 23045050
[TBL] [Abstract][Full Text] [Related]
9. Recommended protocol for the Syrian hamster embryo (SHE) cell transformation assay.
Maire MA; Pant K; Phrakonkham P; Poth A; Schwind KR; Rast C; Bruce SW; Sly JE; Bohnenberger S; Kunkelmann T; Schulz M; Vasseur P
Mutat Res; 2012 Apr; 744(1):76-81. PubMed ID: 22198328
[TBL] [Abstract][Full Text] [Related]
10. Use of the Syrian hamster embryo (SHE) cell transformation assay for predicting the carcinogenic potential of chemicals. Introduction.
Yamasaki H
Mutat Res; 1996 Sep; 356(1):1-3. PubMed ID: 8841472
[No Abstract] [Full Text] [Related]
11. Prevalidation study of the Syrian hamster embryo (SHE) cell transformation assay at pH 7.0 for assessment of carcinogenic potential of chemicals.
Maire MA; Pant K; Poth A; Schwind KR; Rast C; Bruce SW; Sly JE; Kunz-Bohnenberger S; Kunkelmann T; Engelhardt G; Schulz M; Vasseur P
Mutat Res; 2012 Apr; 744(1):64-75. PubMed ID: 22227405
[TBL] [Abstract][Full Text] [Related]
12. Choline supplementation inhibits diethanolamine-induced morphological transformation in syrian hamster embryo cells: evidence for a carcinogenic mechanism.
Lehman-McKeeman LD; Gamsky EA
Toxicol Sci; 2000 Jun; 55(2):303-10. PubMed ID: 10828261
[TBL] [Abstract][Full Text] [Related]
13. Testing of known carcinogens and noncarcinogens in the Syrian hamster embryo (SHE) micronucleus test in vitro; correlations with in vivo micronucleus formation and cell transformation.
Fritzenschaf H; Kohlpoth M; Rusche B; Schiffmann D
Mutat Res; 1993 Sep; 319(1):47-53. PubMed ID: 7690458
[TBL] [Abstract][Full Text] [Related]
14. Miniaturization of cytotoxicity tests for concentration range-finding studies prior to conducting the pH 6.7 Syrian hamster embryo cell-transformation assay.
Plöttner S; Käfferlein HU; Brüning T
Mutat Res; 2013 Aug; 755(2):108-14. PubMed ID: 23830925
[TBL] [Abstract][Full Text] [Related]
15. Classification of agents using Syrian hamster embryo (SHE) cell transformation assay (CTA) with ATR-FTIR spectroscopy and multivariate analysis.
Ahmadzai AA; Trevisan J; Pang W; Riding MJ; Strong RJ; Llabjani V; Pant K; Carmichael PL; Scott AD; Martin FL
Mutagenesis; 2015 Sep; 30(5):603-12. PubMed ID: 25925069
[TBL] [Abstract][Full Text] [Related]
16. Photo catalogue for the classification of cell colonies in the Syrian hamster embryo (SHE) cell transformation assay at pH 6.7.
Bohnenberger S; Bruce SW; Kunkelmann T; Pant K; Perschbacher S; Schwind KR; Sly J; Poth A
Mutat Res; 2012 Apr; 744(1):82-96. PubMed ID: 22212200
[TBL] [Abstract][Full Text] [Related]
17. Photo catalogue for the classification of cell colonies in the Syrian hamster embryo (SHE) cell transformation assay at pH 7.0.
Maire MA; Rast C; Vasseur P
Mutat Res; 2012 Apr; 744(1):97-110. PubMed ID: 22207274
[TBL] [Abstract][Full Text] [Related]
18. Morphological transformation of Syrian hamster embryo cells at pH 6.7 by bemitradine, a nongenotoxic carcinogen.
Oshiro Y; Balwierz PS; Morris DL; Alden CL; Bunch RT
In Vitr Mol Toxicol; 2001; 14(2):121-7. PubMed ID: 11690565
[TBL] [Abstract][Full Text] [Related]
19. Assessing the predictiveness of the Syrian hamster embryo cell transformation assay for determining the rodent carcinogenic potential of single ring aromatic/nitroaromatic amine compounds.
Kerckaert GA; LeBoeuf RA; Isfort RJ
Toxicol Sci; 1998 Feb; 41(2):189-97. PubMed ID: 9520355
[TBL] [Abstract][Full Text] [Related]
20. Prevalidation study of the Syrian hamster embryo (SHE) cell transformation assay at pH 6.7 for assessment of carcinogenic potential of chemicals.
Pant K; Bruce SW; Sly JE; Kunkelmann T; Kunz-Bohnenberger S; Poth A; Engelhardt G; Schulz M; Schwind KR
Mutat Res; 2012 Apr; 744(1):54-63. PubMed ID: 22178964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
